The objectives of the Cancer Research Informatics Core (CRIC) are: 1. To maintain a cost effective research informatics resource for Cancer Center investigators. 2. To coordinate with the Biostatistics Core Resource, the Translational Pathology Core, the Microarray Core Facility and the Clinical Investigations Support Office (CISO) all research data management and computing requirements for Cancer Center investigators. 3. To safeguard confidentiality/privacy of the patient specific clinical information. Over the last 12-18 months, the NCI has identified the need to modernize its processes incorporating the new tools of electronic commerce. This undertaking is being called the Cancer Informatics Infrastructure (CII). The goals of this program include: the creation of an enterprise for both basic and clinical research in cancer; the use of standards to insure the interoperability of information systems; and, the simplification of the clinical trials process from inception to publication, in a secure and user specific way. A fundamental priority in this process is the security and confidentiality of patient specific information. These goals on a national scale are highly compatible with the goals of the CRIC at the local level, i.e., to provide comprehensive informatics support to the Center's research community. This is reflected by the central cancer research database that has been created along with a number of disease-specific databases that have also been established. The focus of this Core resource is to build on this existing base, to design and develop additional disease- specific databases and modify those currently existing, when required, to support the varied research efforts of the Cancer Center's investigators.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA014089-26S1
Application #
6504901
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2001-04-06
Project End
2001-11-30
Budget Start
Budget End
Support Year
26
Fiscal Year
2001
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Lang, Julie E; Brownson, Kirstyn E (2018) ASO Author Reflections: The Whole Transcriptome Landscape of Circulating Tumor Cells in Nonmetastatic Breast Cancer. Ann Surg Oncol :
Poulard, Coralie; Baulu, Estelle; Lee, Brian H et al. (2018) Increasing G9a automethylation sensitizes B acute lymphoblastic leukemia cells to glucocorticoid-induced death. Cell Death Dis 9:1038
Guo, Yu; Perez, Andrew A; Hazelett, Dennis J et al. (2018) CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops. Genome Biol 19:160
Milam, Joel; Slaughter, Rhona; Tobin, Jessica L et al. (2018) Childhood Cancer Survivorship and Substance Use Behaviors: A Matched Case-Control Study Among Hispanic Adolescents and Young Adults. J Adolesc Health 63:115-117
Singh, Hardeep P; Wang, Sijia; Stachelek, Kevin et al. (2018) Developmental stage-specific proliferation and retinoblastoma genesis in RB-deficient human but not mouse cone precursors. Proc Natl Acad Sci U S A 115:E9391-E9400
Suenaga, Mitsukuni; Schirripa, Marta; Cao, Shu et al. (2018) Potential role of PIN1 genotypes in predicting benefit from oxaliplatin-based and irinotecan-based treatment in patients with metastatic colorectal cancer. Pharmacogenomics J 18:623-632
Tsai, Yuan-Li; Ha, Dat P; Zhao, He et al. (2018) Endoplasmic reticulum stress activates SRC, relocating chaperones to the cell surface where GRP78/CD109 blocks TGF-? signaling. Proc Natl Acad Sci U S A 115:E4245-E4254
Rodrigues, Luana L S; Morgado, Mariza G; Sahasrabuddhe, Vikrant V et al. (2018) Cervico-vaginal self-collection in HIV-infected and uninfected women from Tapajós region, Amazon, Brazil: High acceptability, hrHPV diversity and risk factors. Gynecol Oncol 151:102-110
Valentin-Torres, Alice; Savarin, Carine; Barnett, Joslyn et al. (2018) Blockade of sustained tumor necrosis factor in a transgenic model of progressive autoimmune encephalomyelitis limits oligodendrocyte apoptosis and promotes oligodendrocyte maturation. J Neuroinflammation 15:121
Ricker, Charité N; Koff, Rachel B; Qu, Chenxu et al. (2018) Patient communication of cancer genetic test results in a diverse population. Transl Behav Med 8:85-94

Showing the most recent 10 out of 842 publications